Abstract

Short-chain prebiotic fructo-oligosaccharides (FOS) produced by enzymatic conversion from sucrose often contains high concentration of monosaccharides as byproducts. In addition to conventional physical/chemical purification processes, microbial treatment is an alternative method to remove these byproducts. We used Bacillus coagulans to reduce the abundance of byproducts during the enzymatic production of FOS. It is a promising probiotic because this thermophilic and spore-forming bacterium remains viable and stable during food processing and storage. B. coagulans also produces lactic acid during the carbohydrate metabolism and is used industrially to produce lactic acid for medical and food/feed applications. We aimed to establish an evaluation system to screen different strains of B. coagulans for their performance and selected B. coagulans Thorne for the treatment of crude FOS due to its high growth rate, high sporulation rate, and low nutrient requirements. B. coagulans preferentially utilized monosaccharides over other sugar components of the FOS mixture. Glucose and fructose were completely consumed during the fermentation but 85% (w/w) of the total FOS remained. At the end of the fermentation, the total viable cell count of B. coagulans Thorne was 9.9 × 108 cfu·mL−1 and the maximum endospore count was 2.42 × 104 cfu·mL−1.

Highlights

  • Fructo-oligosaccharides (FOS) are oligosaccharides comprising a sucrose molecule extended by a small number of fructose residues

  • The four strains of B. coagulans were cultivated in MRS medium with an initial glucose concentration of 20 g·L−1 to compare their growth rates

  • Four B. coagulans strains were characterized in terms of their biomass accumulation, sporulation capacity, and nutrient requirements

Read more

Summary

Introduction

Fructo-oligosaccharides (FOS) are oligosaccharides comprising a sucrose molecule extended by a small number of fructose residues. The prebiotic activity of FOS has been established in many animal studies and clinical trials, demonstrating their beneficial effects on the immune system, resistance to infection, mineral absorption, and the maintenance of low serum lipid and cholesterol levels [1,2,3]. They inhibit pathogens by stimulating certain probiotic gastrointestinal bacteria [4,5,6]. FOS are comparable in sweetness to sucrose but are only digested to a limited degree by enzymes in the upper part of the gastrointestinal tract [7,8]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.